Clinical Trial Update: Phase II Multicenter, Open-label, Single Arm Clinical Study of Pomalidomide and dexamethasonE and Cyclophosphamide [Phase 2]

View source ↗

Summary

A Phase II multicenter, open-label, single-arm study evaluating pomalidomide with dexamethasone and cyclophosphamide in relapsed or refractory multiple myeloma …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Or Refractory Multiple Myeloma

Drugs mentioned

• Cytoxan (cyclophosphamide)
• Decadron (Dexamethasone)
• Pomalyst (pomalidomide)

Snippet

Sponsor: University Hospital Tuebingen | Conditions: Relapsed or Refractory Multiple Myeloma | Phase 2 | Status: COMPLETED